Where to start

OxyRevo

OxyRevo Quest30 1.5 to 2.0 ATA Hard Hyperbaric Chamber

Stainless Steel Construction2.0 ATA PressureOngoing US-Based Phone Support

$24,999

View model ›

Kohler

Kohler C2 Outdoor Traditional Sauna Kit, Weathered Grey Spruce, Up to 6 Persons

Outdoor-Rated Design6-Person CapacityOngoing US-Based Phone Support

$35,813.33

View model ›

What Lyme Disease Actually Does to the Body

Lyme disease is caused by the bacterium Borrelia burgdorferi, transmitted through the bite of infected black-legged ticks. The infection is straightforward to treat in its early stages, but for a significant number of people, symptoms persist long after antibiotic treatment ends. That persistent picture, sometimes called post-treatment Lyme disease syndrome or chronic Lyme, is where things get complicated and where people start looking beyond standard medicine.

The bacteria create problems through several mechanisms at once. They trigger a sustained inflammatory response that can affect the joints, nervous system, and heart. In some cases, Borrelia appears to burrow into tissues and adopt a low-metabolism form that antibiotics struggle to reach. The result is fatigue that does not resolve with rest, neurological symptoms such as brain fog and nerve pain, muscle aches, and sleep disruption that can persist for months or years.

One detail that matters here is oxygen. Many of the tissues most affected by Lyme, particularly joints and areas with poor circulation, are already relatively low in oxygen. Pathogens like Borrelia tend to thrive in oxygen-poor environments. That biological fact is one of the reasons hyperbaric oxygen therapy has attracted attention as a potential complementary approach.

How Hyperbaric Oxygen Therapy Works

Hyperbaric oxygen therapy means breathing concentrated oxygen inside a pressurized chamber. At normal atmospheric pressure, the oxygen your blood can carry is limited by how much hemoglobin is available to bind it. Pressure changes that equation. When the ambient pressure rises above 1.0 ATA (one atmosphere absolute, which is sea level pressure), oxygen dissolves directly into the blood plasma rather than relying on hemoglobin alone. The result is a significant increase in the amount of oxygen reaching tissues throughout the body.

The typical clinical range for HBOT protocols runs from 1.5 ATA to 2.4 ATA depending on the condition being treated. At those levels, oxygen-rich plasma penetrates areas with compromised blood flow that red blood cells cannot easily reach. This matters for inflammation, wound healing, and immune function, all areas where Lyme patients tend to struggle.

Beyond simple oxygen delivery, elevated pressure triggers a cascade of secondary effects. Studies on HBOT have documented reductions in inflammatory cytokines, stimulation of stem cell release from bone marrow, and enhanced activity of white blood cells. It also appears to suppress the growth of certain anaerobic and microaerophilic organisms, meaning bacteria that need low-oxygen environments to survive. Borrelia burgdorferi falls into that category.

The Science Behind HBOT for Lyme Disease

The research is still developing, and it would be dishonest to call HBOT a proven cure for Lyme disease. What does exist is a body of preliminary work, some case series, small trials, and mechanistic studies, that provides a reasonable scientific basis for using it as part of a broader treatment approach.

The most cited clinical work comes from a 1998 study by William Fife and colleagues at Texas A&M University. They treated 91 Lyme disease patients with HBOT at 2.36 ATA for 90 minutes per session over a series of treatments. A substantial proportion of participants reported meaningful improvements in fatigue, cognitive function, pain, and general quality of life. The study was not a randomized controlled trial, which limits the conclusions you can draw, but the scale and the consistency of patient outcomes made it influential in integrative medicine circles.

The mechanistic argument is more solid. Borrelia burgdorferi is classified as microaerophilic, meaning it prefers and thrives in low-oxygen conditions. Flooding tissues with dissolved oxygen creates an environment the bacteria find hostile. Separately, the anti-inflammatory effects of HBOT are well documented across multiple conditions, and reducing the inflammatory burden in post-treatment Lyme patients addresses one of the core drivers of ongoing symptoms regardless of whether live bacteria are still present.

Research also suggests HBOT supports mitochondrial function and helps reset the oxidative stress response. Many people with chronic Lyme symptoms show markers of elevated oxidative stress, and some of the persistent fatigue and cognitive symptoms appear linked to mitochondrial dysfunction rather than ongoing infection. On those grounds, HBOT has a plausible mechanism even in cases where antibiotic therapy has been completed.

What Specifically HBOT May Target in Lyme Patients

Lyme disease rarely presents as a single problem. Most people dealing with persistent symptoms have several overlapping issues happening at the same time, and HBOT has potential relevance across more than one of them.

• Neuroinflammation: Brain fog, memory difficulty, and mood changes are common in chronic Lyme. HBOT has been shown in neurological research to reduce inflammation in brain tissue and improve cerebral blood flow, which may partially explain cognitive improvements reported by patients.
• Joint inflammation: Lyme arthritis, particularly in the knee, can be severe and debilitating. Elevated oxygen levels in joint fluid may reduce inflammatory mediators and support tissue repair in ways that systemic anti-inflammatories do not always achieve.
• Immune dysregulation: Some post-treatment Lyme patients show evidence of persistent immune activation. HBOT modulates the immune response rather than simply suppressing it, which is a meaningful distinction when the immune system is dysregulated rather than overactive in a straightforward way.
• Fatigue and mitochondrial health: The profound fatigue many Lyme patients describe correlates with reduced cellular energy production. HBOT appears to support mitochondrial efficiency and ATP synthesis, addressing this at a cellular level.
• Peripheral neuropathy: Nerve pain, tingling, and sensory disturbances are common Lyme symptoms. There is a body of research showing HBOT supports nerve regeneration in other neuropathic conditions, and some Lyme patients report improvement in these symptoms during treatment.

Home HBOT Versus Clinic-Based Treatment: Practical Differences

For most people exploring HBOT for Lyme-related symptoms, clinic-based treatment is the starting point. Clinics typically operate at pressures of 2.0 ATA or higher and can administer pure oxygen through a mask, which is the setup used in most formal research protocols. The drawback is cost and logistics. A single clinic session can run anywhere from several hundred to over a thousand dollars, and protocols for Lyme typically involve 40 to 80 sessions. That adds up quickly, and most insurance plans do not cover HBOT for Lyme disease because it remains an off-label use.

Home hyperbaric chambers have become a practical alternative for people who need sustained, long-term access. A personal hard-shell chamber operating at 1.5 to 2.0 ATA delivers meaningfully elevated oxygen levels, and the ability to use it daily or multiple times per week changes the economics and the consistency of treatment significantly.

The OxyRevo Quest30, for example, operates across a working pressure range of 1.5 to 2.0 ATA. It uses a reinforced stainless steel build, includes dual transparent windows, internal control panels for independent operation, and a safety depressurization system. The air cooling and anion purification systems keep the interior environment comfortable for longer sessions. At $24,999, the upfront cost is substantial, but for someone facing 60 clinic sessions at several hundred dollars each, the numbers can converge fairly quickly. People with hyperbaric chambers at home also report that the low barrier to access changes their usage patterns, making it much easier to stay consistent with protocols.

What an HBOT Protocol for Lyme Actually Looks Like

There is no universally agreed-upon HBOT protocol for Lyme disease. The Fife study used 2.36 ATA for 90 minutes per session. Integrative practitioners working with chronic Lyme patients often start at lower pressures, around 1.5 ATA, and work upward as tolerance is established. Session frequency ranges from daily use to five days per week during intensive phases, tapering to maintenance sessions once improvement is observed.

1. Establish a baseline

   Before starting any HBOT protocol, document your current symptoms in detail. Fatigue levels, cognitive clarity, pain scores, sleep quality, and any neurological symptoms should all be tracked so you have an objective record to compare against as sessions accumulate.

2. Start at a lower pressure

   Most integrative practitioners recommend beginning at 1.5 ATA and staying there for the first 10 to 20 sessions. This allows your body to adapt and helps identify any early reactions before increasing pressure.

3. Expect a potential initial flare

   Some people experience a temporary worsening of symptoms in the early sessions. This is thought to reflect a die-off response as oxygen-hostile bacteria are suppressed. It generally resolves within one to two weeks of continued treatment.

4. Commit to a full course

   Meaningful results in the existing case literature came after 40 or more sessions. Expecting results after five or ten sessions is not realistic. If you are using a home chamber, plan your schedule around consistency rather than intensity.

5. Re-evaluate and adjust

   Revisit your symptom baseline every 20 sessions. This gives your physician objective data to work with and helps determine whether pressure, duration, or frequency needs to be modified for your specific response.

Safety Considerations and Contraindications

HBOT has a strong safety record when used within appropriate pressure ranges and with proper equipment. The risks that do exist are mostly pressure-related. Middle ear discomfort or barotrauma is the most common complaint, particularly during pressurization. Equalizing pressure by swallowing, yawning, or using the Valsalva maneuver resolves this for most people. Sinus discomfort can occur for similar reasons.

Oxygen toxicity is a concern at higher pressures (above 2.0 ATA) with prolonged pure-oxygen exposure, which is why session durations and pressure levels are calibrated carefully in clinical settings. At the 1.5 to 2.0 ATA range used in most home chambers with ambient air, the risk profile is considerably lower.

There are genuine contraindications. People with untreated pneumothorax (collapsed lung) should not use HBOT. Those with certain types of respiratory disease, uncontrolled high fever, or a history of seizures should discuss risks carefully with a physician before starting. Some medications, particularly certain chemotherapy drugs, interact with elevated oxygen in ways that require medical supervision.

For Lyme patients specifically, the initial symptom flare mentioned above is worth taking seriously. It can be alarming if you are not expecting it. Having a physician aware of your protocol means you have someone to consult when that happens rather than guessing whether to continue.

Using HBOT Alongside Other Lyme Disease Treatments

HBOT is not a replacement for standard Lyme disease treatment. Antibiotic therapy remains the primary intervention for active infection, and HBOT is most relevant as a complementary approach, particularly for patients in the post-treatment phase who continue to experience symptoms despite completing antibiotic courses.

The combination most commonly discussed in integrative Lyme medicine is HBOT alongside anti-inflammatory nutritional support, mitochondrial support protocols, and sometimes low-dose naltrexone for immune modulation. These approaches target different aspects of the same problem set, and there is reasonable logic to using them in parallel. The general wellness ecosystem supports this kind of multi-modal approach, and you can explore the broader range of equipment used in recovery-oriented wellness routines through general wellness tools designed with this in mind.

Some practitioners also combine HBOT with infrared sauna use, which is thought to support the removal of metabolic waste products through sweating and to reduce the inflammatory load through a different mechanism. The two modalities are not used in the same session but can be scheduled on the same day or in alternating patterns. The important principle is coordination: your treating physician should know everything you are doing, because the combined effects can influence how your body responds to each individual intervention.

Air quality is another variable that rarely gets discussed. People spending significant time in a pressurized chamber or any enclosed wellness environment may benefit from cleaner ambient air. Some people integrating HBOT into a full wellness routine also incorporate air purifiers in their treatment space, particularly those with HEPA and activated carbon filtration, to minimize airborne irritants during and after sessions.

An Honest Assessment of Where the Evidence Stands

Anyone researching HBOT for Lyme will encounter both enthusiastic claims and firm skepticism. The truth is somewhere more nuanced than either camp usually admits. The evidence base is genuinely limited by the standards of modern clinical research. There are no large randomized controlled trials. The studies that exist are small, often uncontrolled, and subject to placebo effects that are difficult to rule out in a condition where subjective symptom reporting is the primary outcome measure.

At the same time, dismissing HBOT for Lyme disease entirely requires ignoring a plausible mechanistic framework and a consistent pattern of patient-reported improvement across multiple case series. Research on HBOT in other inflammatory and infectious contexts is substantially more robust, and many of those findings translate logically to the Lyme disease picture. The honest position is that the evidence is promising but incomplete, and that HBOT is most defensible as a complement to evidence-based care rather than a primary treatment.

For people who have exhausted conventional options and are still experiencing significant symptoms, that distinction matters less than it might on paper. The risk profile of HBOT used at appropriate pressures is low, the mechanistic rationale is sound, and the existing clinical reports are directionally positive. That combination makes it a reasonable option to explore with a physician who is familiar with the protocol literature.

What it is not is a quick fix. Patients who respond well in the existing case literature did so after sustained, consistent treatment over many weeks. The people most likely to benefit are those who approach it with realistic expectations, proper medical oversight, and a willingness to track their response systematically rather than hoping for a dramatic turnaround after a handful of sessions.

More cross topic worth a look

SaunaLife

SaunaLife G11 8 Person Outdoor Traditional Sauna Suite with Lounge Area, Natural Light & Dimmable Lighting

Outdoor-Rated Design8-Person CapacityOngoing US-Based Phone Support

$14,990

View model ›

Medical Breakthrough

Medical Breakthrough 9 Massage Chair - Full-Body Relief With 167 Air Cells & Advanced Systems

Quality Inspected Before ShippingOngoing US-Based Phone Support

$12,599

View model ›

Frequently asked questions